A new review in Genes & Diseases examines how circular RNAs, or circRNAs, could help scientists understand and control one...

Researchers at Baylor College of Medicine have developed an experimental anticancer compound that appears to make treatment-resistant tumors vulnerable again....

Jacksonville, Fla. — Mayo Clinic researchers have used artificial intelligence to identify an experimental small-molecule drug that targets a protein...

Cell-based immunotherapy is moving from a largely experimental concept toward a more standardized form of medicine, according to a new...

Glioblastoma, the most common and aggressive primary brain cancer in adults, has yielded thousands of previously hidden genetic clues in...

Gastric cancer has long presented oncologists with a difficult biological puzzle: two tumors that look similar under a microscope can...

Cancer cells are often described as metabolic opportunists: they reshape the way they use nutrients so they can grow rapidly,...

Lung cancer’s spread to bone is one of the most destructive stages of the disease, often causing severe pain, fractures,...

A decade-long international effort has produced the largest publicly available collection of patient-derived cancer organoids to date, giving researchers a...

For nearly a decade, the Cancer Dependency Map, known as DepMap, has helped researchers identify the genetic weaknesses that cancer...